Analysis procedures
Adaptation of a polyclonal assay for use on the Cobas Bio centrifugal analyser has been reported," and a similar method was developed for the monoclonal assay. Calibrator concentrations for the monoclonal assay were 0,500, 1000, 1667, 2333 and 3000 I-'g/L. Other test parameters were the same as for the polyclonal assay with the exception of sample, diluent and start reagent volumes (17, 70 and 171-'L) and the blanking mode (0). The criteria used for acceptance of results for the monoclonal assay were based on the span of the reaction rate difference between standards 6 and 1 (approximately 30), deviations of the individual standard rates from the best fit curve « 1. 5), and the standard deviation of differences « I . 5).
The manufacturer's recommended threshold limits of 300 I-'g/L and 1000 I-'g/L for the polyclonal and monoclonal assays, respectively, were used to classify results as positive or negative. Quantitative results were obtained by using multi-point calibration.'? Confirmation of amphetamines by GC-MS Urine samples were extracted using Bond Elut CertifyTM solid-phase extraction columns (Varian Sample Preparation Products, Harbor City, CA, USA). The manufacturer's amphetamines extraction procedure was followed, except that, instead of dimethylformamide, 0'1 mL methanoll concentrated HCI (99:1 by volume) was added to the extract halfway through the evaporation step to minimize loss of the amphetamine bases. After evaporation, amphetamines in the dry residue were derivatized by adding 21-'L pyridine and 10 I-'L acetic anhydride and heating for 10 min at 60°C. Ethyl acetate (50I-'L) containingO·125 giL ethyl palmitate was added and II-'L injected into the gas chromatography (GC). Amphetamine acetyl derivatives were identified by comparison with known compounds on the basis of their mass spectra and their retention times relative to ethyl palmitate. ·Manufacturer's recommended threshold limits: polyclonal assay 300,.g/L; monoclonal assay 1000,.g/L.
The instrument was a Hewlett-Packard 5890 series 2 GC with splitless injection and 5971A mass-selective detector. The column was DB-5MS, 30 m long, 0·25 mm internal diameter and O' 25 JLm film thicknesss (1 & W Scientific, Folsom, CA, USA). Initial oven temperature was 60°, held for 1 min, rising at 60°/min to 120°then at 8°/min to 300°, held at 300°for 5· 5 min. Detection was full-scan from 40-300 amu..
RESULTS
Results of analysis of 553 urines by the EMIT d.a.u. polyclonal and monoclonal assays are summarized in Table 1 . The same results, positive or negative, were obtained for 90070 of the urines; 12% of the samples gave positive results by the polyclonal method compared to 9% by the monoclonal method. Some urines (n = 76) were analysed by GC-MS and the results compared with those from the EMIT assays (Table 2) . Of the 35 urines found to contain amphetamine either alone or in the presence of amphetamine-related compounds, all gave positive results by the polyclonal assay, but only 16 tested positive by the monoclonal assay. The 19 urines giving negative results by the monoclonal assay had 'amphetamines' concentrations in the range 0-944 JLg/L (mean 487 JLg/L). Two samples in which ephedrine/ pseudoephedrine were detected tested positive by the polyclonal assay and negative by the monoclonal assay; when phenylpropanolamine was also present, all assays gave positive results.
Positive results were obtained by the polyclonal assay for all urines in which methylenedioxymethamphetamine (MDMA) and/or methylenedioxyamphetamine (MDA) were detected by GC-MS ( Table 2 ). The two urines testing negative by the monoclonal assay had measured concentrations of 442 and 932 JLg/L.
Positive results were obtained by the polyclonal and/or monoclonal assays ( Table 2 ) for some of the 12 urines with no detectable amphetamines and related compounds by GC-MS.
Of the 16 samples in which GC-MS analysis indicated the presence of phenothiazine metabolites but no amphetamines, only one gave a positive test (> 1500 JLg/L) by the polyclonal Moore, Jarvie and Simpson assay while 14 tested positive (l235-3000 /Lg/L) by the monoclonal assay. In a more detailed investigation of urines from patients given phenothiazines, 12 urines in which chlorpromazine metabolites were found by GC-MS tested positive by the monoclonal assay; only one urine gave a positive result by the polyclonal assay. Two urines in which trifluoperazine metabolites were detected tested positive by the monoclonal assay and negative by the polyclonal assay. In contrast, two urines in which thioridazine metabolites were detected gave negative results by both assays. Two urines in which trazodone metabolites were detected tested positive by the polyclonal assay and negative by the monoclonal assay.
The effect of heating on amphetamines was investigated previously'? and found to produce a mean decrease of 140/0 in the measured result. The effect of heating on eight urines containing MDMA and/or MDA was investigated. Mean concentrations measured by the polyclonal assay before and after heating were 630/Lg/L (range 127-1344 /Lg/L) and 620/Lg/L (range 142-1321 /Lg/L), respectively. The corresponding concentrations for the monoclonal assay were 1772 /Lg/L (range 929-3098 /Lg/L) before heating and 1782/Lg/L (range 910-2757/Lg/L) after heating.
DISCUSSION
In this study, qualitative results by the EMIT d.a.u. polyclonal and monoclonal assays were the same for 900/0 of the 553 urines tested.
Quantitative results for amphetamine and MDMA were greater by the monoclonal assay than by the polyclonal assay but in some cases application of a higher threshold level (lOOO /Lg/L) gave rise to false negative results. The two samples in which only ephedrine/pseudoephedrine was detected tested negative by the monoclonal assay, but when phenylpropanolamine was also present there was no evidence of this decreased crossreactivity compared to the polyclonal assay.
Positive results by the monoclonal assay for urines in which no amphetamines were detected by GC-MS, suggest possible greater sensitivity of the immunoassay. This suggestion does however appear to be untenable since false negative results were obtained for several samples in which amphetamines were detected by GC-MS and by the polyclonal assay ( Table 2) .
The threshold levels used for the immunoassays were those recommended by the manufacturers.
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We did, however, investigate the use of a 300 /Lg/L cut-off for both assays and found that this did not affect the overall finding that 90% of urines gave the same results by both assays. This lower cut-off value increased the number of positives by the monoclonal assay from 16 to 31 of the 35 urines in which amphetamine was detected by GC-MS. Use of a lower threshold level did not affect the number of positive results for urines in which no amphetamines were detected by GC-MS.
In our experience of routine use of the EMIT d.a.u. monoclonal amphetamines assay there was little evidence of improvement over the polyclonal assay. Cross-reactivity with some phenothiazine metabolites could give false-positive results when screening for suspected drug-induced psychosis and this could be a serious disadvantage (in our laboratory about 10% of urines are from patients in psychiatric hospitals or attending psychiatric clinics, many of whom are on phenothiazine therapy).
The cost of basic materials for the EMIT d.a.u. assays is about 25 pence per test using diluted reagents. 10 Syva have introduced an EMIT II monoclonal assay kit which is reported to be more specific than the EMIT d.a.u. monoclonal assay.'! The manufacturers claim that the assay does not detect chlorpromazine at concentrations up to 600 mg/L, or thioridazine and trifluoperazine at concentrations up to 100 mg/L, but information about the cross-reactivity of phenothiazine metabolites does not seem to be available.
Our findings would support the recommendatiorr' that the d.a.u. polyclonal assay be used as a screening procedure for amphetamines as it can screen out the high proportion of negative urines and detect several drugs related to amphetamine (for example, phentermine, mephentermine, ephedrine) which are misused. Identification and confirmation can be carried out by a chromatographic method, preferably GC-MS if this technique is available.
